Donald Trump’s claims of unprecedented business investment during his presidency have come under scrutiny. While he boasts figures in the trillions, suggesting a new economic golden era, analysis reveals these numbers are significantly inflated, often including pre-existing projects or non-investment spending. Experts suggest the actual impact is far more modest, with policy uncertainty potentially hindering growth.
Unpacking Trump’s Investment Claims
Former US President Donald Trump frequently touted astonishing figures for business investment during his tenure, claiming over $12 trillion had been "practically committed." He attributed this supposed surge to his policies, including tariffs, tax cuts, and deregulation. If accurate, this figure would dwarf the typical annual gross private investment in the US, which is around $4 trillion.
The Reality Behind The Numbers
Despite Trump’s bold assertions, a closer look at the data and company announcements reveals a different picture. Official government statistics on business investment are released quarterly, and while there was a jump in early 2017, analysts noted it was partly skewed by an earlier Boeing strike. Furthermore, many of the high-profile investment promises cited by the White House were either already in progress before Trump took office or included spending not traditionally classified as investment.
- Inflated Figures: The White House’s own running tally of new investments, at $5.3 trillion, was less than half of Trump’s stated figure. Even this lower number was inflated.
- Pre-existing Projects: Approximately one-third of the 62 investments on the White House list were at least partially planned before Trump’s presidency. For example, Corning’s $1.5 billion investment included a core $900 million announced in early 2024, and Stellantis’s $5 billion plan was initially promised in 2023.
- Non-Investment Spending: Some commitments, like Apple’s $500 billion pledge, encompassed taxes and salaries, not just new capital investment.
Expert Analysis And Discrepancies
According to analysis by Goldman Sachs, the actual new investment stemming from these announcements likely totalled closer to $134 billion by mid-May, shrinking to as little as $30 billion when accounting for projects that might not materialise or would have happened anyway. Economists like Nick Bloom of Stanford University suggest that overall business investment might even be slightly down due to high uncertainty.
White House spokesman Kush Desai dismissed concerns about the discrepancies, asserting that the administration’s multifaceted approach was driving investment, regardless of "pointless nitpicking."
Incentives And Long-Term Outlook
Experts suggest that companies may have an incentive to exaggerate investment plans to flatter the administration, especially given Trump’s willingness to intervene in the economy through policies like tariffs. While tariffs have indeed acted as a catalyst for some pharmaceutical firms to plan more US manufacturing, these investments are often long-term and in sectors already poised for growth.
However, policy uncertainty, particularly regarding tariffs and drug pricing, could jeopardise these plans in the long run. Many analysts anticipate a slowdown in US investment growth this year. Economist German Gutierrez argues that while boosting investment is a valid goal, Trump’s approach, particularly tariffs, may not address the underlying issues, such as industry consolidation and a shift towards cheaper, software-based investments rather than large-scale factories.
